Klaria AB

Klaria AB is a dynamic pharmaceutical company dedicated to developing innovative pharmaceuticals, with a focus on addressing critical needs such as migraine, cancer-related pain, and opioid overdoses. Klaria AB is committed to improving patient outcomes through advanced drug delivery systems and novel therapeutic approaches.

Located at Virdings Allé 2, Uppsala Businesspark, Uppsala 754 50, SE, Klaria AB operates as a public company, driving forward advancements in pharmaceutical manufacturing. Klaria AB’s strategic focus on innovative drug development positions it as a key player in the evolving healthcare landscape.

With a strong emphasis on research and development, Klaria AB aims to provide effective solutions that enhance the quality of life for individuals facing significant health challenges. We invite the management of Klaria AB to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.